Fertility of young mares after long-term anabolic steroid treatment

The effect of prior treatment with anabolic steroids was studied in 46 three-year-old mares. In the preceding year, these mares had been assigned to 1 of 4 treatment groups and had received the manufacturer's recommended dosage of 1.1 mg of boldenone undecylenate (BU)/kg of body weight, 4.4 mg of boldenone undecylenate (4 BU)/kg, 1.1 mg of nandrolone decanoate (ND)/kg, or 0.04 ml of sesame oil/kg (control, C). Mares had received an injection every 3 weeks for 54 weeks for a total of 19 injections, with the final injection in December. In the following breeding season, fewer (P less than 0.05) mares in all groups previously administered anabolic steroids displayed estrous behavior than did mares in the control group. Duration of estrus was shortened (P less than 0.05) in mares that had received steroids. Abnormal sexual behavior that was observed during steroid treatment continued (P less than 0.05) for up to 6 months after treatment ceased. However, observations of abnormal behavior declined with time (P less than 0.05). All mares in each treatment group ovulated by the end of the trial, and the interval to first ovulation was similar (P greater than 0.05). Ovarian size, follicular development, and conditions of the tubular genitalia was adversely (P less than 0.05) affected in mares in all steroid-treatment groups until approximately the middle of March. After that time, no difference was noted among groups. First-cycle pregnancy rates were 83%, 67%, 50%, and 42% for mares in the untreated, BU, 4 BU, and ND groups, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Effect of age of equine embryos and method of transfer on pregnancy rate

A 2 X 2 cross-classified experiment was conducted to investigate the effect of age of equine embryo (7 vs 8 d postovulation) and method of transfer (surgical vs nonsurgical) on pregnancy rates at 50 d of gestation. Embryos were recovered 7 or 8 d postovulation using a Foley catheter and 3 liters of modified Dulbecco's phosphate-buffered saline (PBS). Upon identification, the embryos were placed in millipore-filtered PBS containing 20% heat-inactivated steer serum and maintained at room temperature until transferred. At the time of recovery, embryos were randomly assigned to be transferred either nonsurgically using a sterile insemination pipette or surgically via a flank incision. For nonsurgical transfer, the embryo was deposited into the uterine body; whereas, in surgical transfer, the embryo was placed in the uterine horn ipsilateral to the corpus luteum. Recovery rates for embryos collected on d 7 (75.5%) or 8 (81.9%) were similar (P greater than .05). Age of embryo did not affect (P greater than .05) pregnancy rate. At 50 d, pregnancy rates were 60 and 57% for mares receiving d 7 or 8 embryos. However, more (P less than .05) pregnancies were obtained after transfer of embryos surgically (72%) than nonsurgically (45%). More (P less than .05) pregnancies were obtained after transfer of d 8 embryos surgically (75%) compared with nonsurgically (40%). Within method of transfer, pregnancy rates were similar (P less than .05) for surgical transfer of d 7 and 8 embryos (69 and 75%), but tended (P less than .25) to be higher for nonsurgical transfer of d 7 embryos (50%) compared with d 8 embryos (40%).(ABSTRACT TRUNCATED AT 250 WORDS)

Extenders for preservation of canine and equine spermatozoa at 5°C

Two experiments were conducted to evaluate the effects of six extenders and three glycerol levels on the motility of sperm stored at 5 degrees C. Using a split-ejaculated design, semen from 10 dogs and 12 stallions was extended with egg-yolk-tris (EYT), egg-yolk-bicarbonate (EGB), Beltsville F-3 (BF-3), Cornell University (CUE), caprogen (CAP) and heated skim milk (SM) extenders. After cooling to 5 degrees C, additional extender containing 0% to 12% glycerol was added to provide a final concentration of 0%, 3% or 6% glycerol. Regardless of glycerol level, a higher (P<0.05) percentage of canine sperm retained their potential for progressive motility in CAP extender than in EYT, SM, CUE, EGB or BF-3 extenders. The SM extender was the best (P<0.05) for maintaining motility of equine sperm. The inclusion of 6% glycerol depressed (P<0.05) motility of canine sperm, but there was no effect (P>0.05) of glycerol concentration on the percentage of motile equine sperm. For both species, the interaction of glycerol level and extender was nonsignificant. CAP may be useful for storage of canine sperm at 5 degrees C and SM may be satisfactory for storage of equine sperm.

Seasonal variation in hypothalamic content of gonadotropin-releasing hormone (GnRH), pituitary receptors for GnRH, and pituitary content of luteinizing hormone and follicle-stimulating hormone in the mare

Seasonal changes in the hypothalamic-hypophyseal axis were investigated using tissue from 49 light-horse mares, of mixed breeding. Hypothalamic and pituitary tissues were collected at 5 intervals throughout the years 1981 and 1982, representing midbreeding season (July, n = 10), transition out of the breeding season (October, n = 11), midanestrus (December, n = 8), transition into the breeding season (March, n = 10), and again in the following midbreeding season (July, n = 10). The hypothalamic region was dissected into preoptic area, body and median eminence. Gonadotropin-releasing hormone (GnRH) was extracted from hypothalamic samples with methanol-formic acid and quantified by radioimmunoassay. The anterior pituitary was homogenized and receptors for GnRH were quantified in a crude membrane fraction. Concentrations of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were measured in the resulting supernatant. Content of GnRH in each of the 3 hypothalamic areas varied with season (P less than 0.01) and was lowest during midanestrus (P less than 0.05). There was no effect of season (P greater than 0.01) on either concentration or total number of receptors for GnRH, or concentration of FSH in the anterior pituitary. Concentrations of LH in the anterior pituitary varied with season (P less than 0.001). Means (+/- SEM) for the 5 collection times were 15.5 +/- 2.7, 9.7 +/- 2.4, 2.3 +/- 0.5, 2.7 +/- 0.4 and 11.7 +/- 1.5 microgram LH/mg anterior pituitary, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

The effect of altrenogest, an oral progestin, on hematologic and biochemical parameters in mares

Twenty mares were assigned to 1 of 4 groups: no altrenogest; altrenogest at 0.044 mg/kg BW; altrenogest at 0.132 mg/kg BW; or altrenogest at 0.220 mg/kg BW. Treatment was administered daily for 86 days. No signs of illness attributable to feeding altrenogest were observed during the trial. Treatment had no effect (P greater than .05) on the following parameters: WBC, differential WBC, platelet number, creatinine, LDH, CPK, total bilirubin, cholesterol, globulin, BSP, and erythrocyte sedimentation rate. When comparing values over time with pretreatment means or among treatment groups, there were differences (P less than .05) in RBC, PCV, Hb, ALT, PT, PTT, P, Na, TP, BUN, Cl and glucose. However, these changes remained within established normal ranges and also occurred in mares in the control group. There was no treatment by time interaction for any of these parameters. Treatment differences (P less than .05) were observed for K, Ca, alkaline phosphatase and AST during the course of the trial. However, only occasional values of these parameters were outside the established ranges. They were only slightly elevated and tended to be either sporadic or also occurred in control mares. Few of the observed changes could be attributed to the feeding of altrenogest.

Fertility of unfrozen and frozen stallion spermatozoa extended in EDTA-lactose-egg yolk and packaged in straws

The fertility of frozen-thawed semen was compared with that obtained using fresh semen extended in skim milk. Semen for freezing was obtained in June from four stallions of unknown fertility; two ejaculates were collected 1 to 2 h apart every 3 or 4 d. The gel-free fraction of the ejaculate was mixed 1:1 with a glucose-EDTA solution (disodium ethylenediaminetetraacetic acid) and centrifuged at 650 x g for 15 min. The spermatozoa were resuspended in an EDTA-lactose-egg yolk extender containing 5% glycerol. Semen was frozen in .5-ml French straws containing 250 x 10(6) progressively motile spermatozoa before freezing. Only for 31% of the 54 ejaculates frozen was post-thaw spermatozoal motility greater than or equal to 50% of the percentage of progressively motile spermatozoa observed during evaluation of the neat semen. Spermatozoa in second ejaculates apparently were more susceptible to the adverse effects of dilution and centrifugation than spermatozoa in first ejaculates. Only samples containing greater than 30% progressively motile spermatozoa after freezing and thawing (at 38 C) were used for insemination. In June and July, 101 mares were inseminated daily with semen from one of three stallions beginning on d 2 and continuing through the end of estrus for one cycle. Mares were inseminated with semen in one straw or with 250 x 10(6) progressively motile spermatozoa extended in 10 ml of skim milk. Because of the poor survival of spermatozoa that had been frozen and thawed, mares inseminated with frozen-thawed semen received 100 to 130 x 10(6) progressively motile spermatozoa as compared with 250 x 10(6) progressively motile spermatozoa for mares inseminated with fresh semen. One cycle pregnancy rates, based on rectal palpation 50 to 60 d after ovulation, were 29% using frozen-thawed semen and 66% using fresh semen (P less than .05). Values for individual stallions were 19, 24 and 47% with frozen semen and 47, 61 and 67% with fresh semen. Routine use of frozen stallion semen is not recommended at this time.

Testosterone effects on mares during synchronization with altrenogest: FSH, LH, estrous duration and pregnancy rate

Twelve mares fed altrenogest for 14 d were used to study the effects of a single injection of testosterone propionate on concentrations of follicle-stimulating hormone (FSH) during diestrus, and to relate the normal and perturbed patterns of FSH secretion to subsequent estrous characteristics and fertility. Seven of 12 mares received testosterone propionate at 200 micrograms/kg of body weight on d 5 of progestogen feeding. Mares were teased and blood samples were drawn daily; all mares were artificially inseminated at the first estrus after progestogen treatment. Testosterone propionate treatment caused a 50% reduction in concentration of FSH in plasma within 24 h, and this effect persisted through 48 h after injection. Within 4 d after the suppression of FSH secretion, concentrations of FSH rebounded and were significantly elevated compared with control values during the last 4 d of progestogen feeding. Testosterone propionate at this dosage also elicited estrous behavior in five of seven treated mares within 24 h after injection. After withdrawal of progestogen feeding, the interval to onset of estrus, duration of estrus, and magnitude of the luteinizing hormone peak were similar between groups (P greater than .05). Six of seven treated mares and three of five control mares became pregnant to breeding on the first estrus after progestogen treatment. Because manipulation of the normal pattern of FSH secretion during diestrus did not affect estrous characteristics or fertility of the subsequent estrus, such treatment may have potential as a means of synchronizing FSH surges during diestrus in the mare.

Effect of anabolic steroids on reproductive function of young stallions

Thirty-two stallions were used to determine the effect of anabolic steroids on reproductive function. Stallions were assigned to one of the four treatments: 1) .23 ml sesame oil/kg of body weight (BW; control, C); 2) 4.4 mg boldenone undecylenate/kg BW (4E); 3) 1.1 mg boldenone undecylenate/kg BW (1E) and 4) 1.1 mg nandrolone decanoate/kg BW (D). Injections were given at 3-wk intervals for 15 wk. Semen was collected every other day for 3 wk before the first injection and at the same frequency during d 85 through 105 (d 0 = day of first injection). Libido was assessed on the basis of reaction time. Total scrotal width was determined every 2 wk. Serum was obtained at various intervals and analyzed for concentrations of luteinizing hormone (LH). Portions of testicular parenchyma were used to determine spermatid reserves and to permit quantitative histological evaluation of spermatogenesis. Gel, gel-free and total seminal volumes and pH were not affected (P greater than .05) by steroid treatment. However, spermatozoal motility, spermatozoal concentration and total sperm/ejaculate were severely lowered (P less than .05) by all anabolic steroid treatments. Total scrotal width for stallions in the D, 4E and 1E groups was less (P less than .05) than that of C stallions by wk 5. The weight of the testes of the D, 4E and 1E stallions averaged only 40.1, 44.9 and 61.6%, respectively, of that for the controls. Spermatozoal production was altered, as evidenced by smaller (P less than .05) numbers of spermatids/testis and primary spermatocytes for all treated groups than for the controls. Anabolic steroid treatment had no effect (P greater than .05) on erection time, time to first mount, ejaculation time or number of mounts/ejaculation. treatment with anabolic steroids resulted in a depression in concentration of LH in all treatment groups.

Collection and transfer of equine embryos

Embryos were recovered in 39 of 47 attempts (83%) during 1979 and in 75 of 104 attempts (72%) during 1980. The mean diameters of day 8 and 9 blastocysts were 1.00 and 2.13 mm, respectively. The injection of prostaglandin F2 alpha or prostalene on day 8 or 9 after ovulation resulted in a mean interval between embryo recovery attempts of 17.7 +/- 0.3 days. Number of embryos recovered within mares did not vary significantly with repeated attempts. Following surgical transfer, 8 of 15 recipients (53%) were pregnant at 50 days after ovulation, whereas only 4 of 15 recipients (27%) were pregnant at 50 days following nonsurgical embryo transfer.

Restoration of reproductive capacity of stallions after suppression with exogenous testosterone

Twelve stallions that had been given 0, 50 or 200 micrograms testosterone propionate (TP)/kg body weight every other day for 88 days were examined for the effects of androgen withdrawal on spermatozoal production, seminal quality and libido. Although the lower dosage did not affect most of the traits studied, the higher dosage severely reduced scrotal width, spermatozoal production, the number of sperm per ejaculate, the percentage of progressively motile spermatozoa and the percentage of normal spermatozoa. These adverse effects were found to be largely reversible. By 90 days after the cessation of treatment, scrotal width, testicular weight and spermatozoal production were similar for treated and control stallions. Although the number of sperm per ejaculate remained lower for stallions given 200 micrograms TP than for controls during the recovery period, the number of sperm in the extragonadal ducts was similar for all groups after 90 days of recovery. Spermatozoal motility and morphological characteristics were normal for all three groups by the end of the recovery period. Libido was not affected by TP treatment or withdrawal.

Sexual behavior, seminal pH and accessory sex gland weights in geldings administered testosterone and(or) estradiol-17 beta

Sixteen stallions were castrated and 30 days later assigned to one of four treatments: (1) testosterone propionate (175 microgram/kg body weight), (2) 17 beta-estradiol-3-benzoate (44 micrograms/kg body weight), (3) a combination of both steroids or, (4) vehicle only. These dosage were administered every other day for 18 days. The dosages were then doubled and continued for 20 days. Concentrations of testosterone and estradiol in serum decreased rapidly after castration and stabilized within about 6 hours. Mean concentrations of testosterone and estradiol maintained by the steroids were 1.4 and 90 pg/ml, respectively, during treatment at the lower dosage, and 2.6 and 186 pg/ml during treatment at the higher dosage. Libido and the ability to ejaculate were gradually lost after castration. Testosterone restored both aspects of sexual behavior within 2 weeks. Estradiol effectively restored libido at the higher dosage, but was less effective in restoring the ability to ejaculate. The pH of gel-free semen increased after castration and was subsequently decreased by treatment with testosterone or the combination of both steroids. Estradiol had no effect on seminal pH. Weights of the seminal vesicles, ampullae and prostate were greater in geldings treated with testosterone or with both steroids than in estradiol-treated or control geldings. Since estradiol alone was able to restore libido in geldings, it is possible that the maintenance of libido in intact stallions involves either estradiol secreted directly by the testes or estradiol arising from aromatization in peripheral tissues. Treatment with estradiol at either concentration, did not appear to affect the size or function of sex glands in geldings.

Temperature of the artificial vagina and its effect on seminal quality and behavioral characteristics of stallions

Stallion semen was collected, using artificial vaginas at 44 to 46, 48 to 50, and 52 to 54 C, to study the effects of temperature on seminal quality and sexual behavior. The temperature of the artificial vagina had no significant effect on motility, gel volume, gel-free seminal volume, total seminal volume, pH, number of mounts per ejaculate, total time to ejaculation, or seminal temperature. Spermatozoa were collected, then exposed to water-bath temperatures of 38, 45, 49, or 53 C for 1 minute. Mean motility was similar after exposure to temperatures of 38 or 45 C, but exposure to temperatures of 49 or 53 C resulted in a significant decrease (P < 0.05) in spermatozoal motility with each increase in temperature. Thus, it was concluded that spermatozoa exposed to temperatures greater than 45 C may be irreversibly damaged.

Acceleration of healing of rabbit corneal endothelium by mesodermal growth factor

Freeze-thaw injuries of rabbit corneas were treated with mesodermal growth factor (MGF) in organ culture and the repair of the endothelium followed by light microscopic examination of endothelial whole mounts. MGF-treated corneas showed an increased number of mitotic figures. In addition, MGF accelerated the rate of cell hypertrophy, formation of spindle-shaped cells, and the rate of their migration into the killed zone so that Descemet's was covered more rapidly than was that of the controls. In MGF-treated corneas, the cells lost their fibroblast-like appearance and became endothelial-like in appearance sooner than did the untreated corneas. A short period of treatment (6 hr) was sufficient to stimulate the repair processes described above. The healing responses obtained in organ culture for control eyes approximately those described in the literature for freeze-thaw injuries to the rabbit endothelium in vivo. The data presented also show that it is possible to accelerate endothelial regeneration in wound healing.

Induction of abortion in mares with equimate: effect on secretion of progesterone, PMSG and reproductive performance

Thirty-two light-horse mares were confirmed to be pregnant and assigned to one of four treatments: (1) injected with 250 micrograms of Equimate on day 70 and again on day 77 if abortion had not occurred; (2) injected with 250 micrograms of Equimate on day 70 and every 24 hr until abortion occurred (maximum four injections); (3) injected with 250 micrograms of Equimate on day 70 and every 12 hr until abortion (maximum eight injections); and (4) injected with 250 micrograms of Equimate once only on day 35 of gestation. Mares were observed four times daily for incidence of abortion or side effects. Estrual behavior was monitored daily and follicular activity either daily or every third or fourth day until estrus and ovulation. Samples of jugular blood were obtained at 0600 hr day -1 and every 6 hr until the first day of estrus after abortion, or for 2 weeks after abortion if estrus had not occurred, or for 1 week after treatment for mares that had not aborted. A single injection of Equimate terminated pregnancy in all but one mare injected on day 35, but none of the mares given an injection on day 70 and 77 aborted. Multiple injections of Equimate beginning on day 70 of gestation terminated pregnancy in all mares. Fewer (P less than .05) injections were required for abortion of mares injected daily. During the immediate week post-treatment, concentrations of progesterone decreased (P less than .05) in all mares injected with Equimate, but overall concentrations were greater (P less than .05) for mares injected once on day 70 than for those in the other three groups. Equimate did not affect secretion of PMSG in the day 70 group of mares. Estrus and ovulation after abortion were delayed (P less than 0.05) for mares injected daily or twice daily beginning on day 70 compared to those injected once on day 35. Thus, rebreeding of these mares during the same breeding season in which they were aborted would be difficult.

Stimulation of corneal wound healing with mesodermal growth factor

Mesodermal growth factor (MGF) from mouse submaxillary glands was tested in vivo for stimulating effects on corneal wounds in rabbits. Intrastromal injection of 5 microgram of MGF induced widespread fibroblast activity and stromal cell division, and markedly stimulated stromal healing. At high doses (greater than 25 microgram), corneal destruction was indicated by extensive necrosis and perforation. When low doses (1 to 5 microgram) of MGF were applied to the lip of nonperforating knife wounds of the cornea, three major differences were noted between control and experimental wounds. In wounds treated with MGF, the depth of stromal healing was greater, as was the intensity of the fibroblast activity, and the width and depth of the epithelial plug were significantly decreased. These results establish that MGF is an effective growth-stimulating agent in vivo and that the initial stages of corneal wound healing may be accelerated in vivo.

Follicular and luteal development in pregnant mares

Examination of the ovaries of mares at various stages of pregnancy and after hysterectomy, together with measurement of progesterone concentrations in the peripheral plasma of pregnant and hysterectomized mares and in uterine and ovarian venous plasma of pregnant mares, demonstrated that the primary CL of pregnancy remains functional until at least Day 160 of gestation. The results showed that primary and secondary CL, and the placenta or uterus, all contribute to the total progesterone pool in mares during pregnancy. Similarities and differences in ovarian function observed between pregnant and hysterectomized mares suggested that, while PMSG does not appear to stimulate follicular development, it does prolong the life-span and stimulate the secretory activity of the primary CL, and induces ovulation and/or luteinization of secondary follicles in pregnant mares.